Stradling client ALPHAEON Corporation repaid approximately $88 Million in third-party debt pursuant to the transfer to certain noteholders of approximately 1.3 Million shares of Evolus, Inc. common stock and the payment of a portion of the cash proceeds from its sale of 4 million shares of Evolus, Inc. common stock in the underwritten public offering with Morgan Stanley. The shares transferred to noteholders are subject to a minimum six-month holding period pursuant to Rule 144 and certain lockup requirements of Morgan Stanley. Read the press release.
ALPHAEON Corporation is a company focused on developing and bringing to market highly innovative healthcare products and services. EVOLUS is a performance beauty company with a customer-centric approach focused on delivering breakthrough products.
Newport Beach-based Marc Alcser and Jason Lee represented ALPHAEON in this transaction.